379 related articles for article (PubMed ID: 19380349)
1. Non-conventional markers of atherosclerosis before and after gastric banding surgery.
Hanusch-Enserer U; Zorn G; Wojta J; Kopp CW; Prager R; Koenig W; Schillinger M; Roden M; Huber K
Eur Heart J; 2009 Jun; 30(12):1516-24. PubMed ID: 19380349
[TBL] [Abstract][Full Text] [Related]
2. Improvement of insulin resistance and early atherosclerosis in patients after gastric banding.
Hanusch-Enserer U; Cauza E; Spak M; Endler G; Dunky A; Tura A; Wagner O; Rosen HR; Pacini G; Prager R
Obes Res; 2004 Feb; 12(2):284-91. PubMed ID: 14981221
[TBL] [Abstract][Full Text] [Related]
3. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
Schernthaner GH; Kopp HP; Krzyzanowska K; Kriwanek S; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 Jun; 36(6):395-401. PubMed ID: 16684123
[TBL] [Abstract][Full Text] [Related]
5. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
6. The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity.
Shargorodsky M; Fleed A; Boaz M; Gavish D; Zimlichman R
Int J Obes (Lond); 2006 Nov; 30(11):1632-8. PubMed ID: 16552402
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
Varo N; Vicent D; Libby P; Nuzzo R; Calle-Pascual AL; Bernal MR; Fernández-Cruz A; Veves A; Jarolim P; Varo JJ; Goldfine A; Horton E; Schönbeck U
Circulation; 2003 Jun; 107(21):2664-9. PubMed ID: 12742991
[TBL] [Abstract][Full Text] [Related]
8. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Corson MA; Jones PH; Davidson MH
Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
[TBL] [Abstract][Full Text] [Related]
9. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery.
Baena-Fustegueras JA; Pardina E; Balada E; Ferrer R; Catalán R; Rivero J; Casals I; Lecube A; Fort JM; Vargas V; Peinado-Onsurbe J
JAMA Surg; 2013 Feb; 148(2):151-6. PubMed ID: 23426590
[TBL] [Abstract][Full Text] [Related]
11. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
Glowinska B; Urban M; Peczynska J; Florys B
Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
[TBL] [Abstract][Full Text] [Related]
12. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass.
Frige' F; Laneri M; Veronelli A; Folli F; Paganelli M; Vedani P; Marchi M; Noe' D; Ventura P; Opocher E; Pontiroli AE
Nutr Metab Cardiovasc Dis; 2009 Mar; 19(3):198-204. PubMed ID: 18684601
[TBL] [Abstract][Full Text] [Related]
13. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
Noto H; Chitkara P; Raskin P
J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
[TBL] [Abstract][Full Text] [Related]
14. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
[TBL] [Abstract][Full Text] [Related]
15. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding.
Uzun H; Zengin K; Taskin M; Aydin S; Simsek G; Dariyerli N
Obes Surg; 2004 May; 14(5):659-65. PubMed ID: 15186635
[TBL] [Abstract][Full Text] [Related]
16. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
Linnemann B; Voigt W; Nobel W; Janka HU
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
[TBL] [Abstract][Full Text] [Related]
18. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A and obstructive sleep apnea syndrome before and after surgically-induced weight loss in morbidly obese subjects.
Poitou C; Coupaye M; Laaban JP; Coussieu C; Bedel JF; Bouillot JL; Basdevant A; Clément K; Oppert JM
Obes Surg; 2006 Nov; 16(11):1475-81. PubMed ID: 17132414
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of atherosclerosis markers in salt-sensitive hypertension.
Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A
Am J Hypertens; 2006 Jan; 19(1):87-93. PubMed ID: 16461197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]